Global HER2 Targeted Therapy Supply, Demand and Key Producers, 2023-2029

Page: 111

Published Date: 30 Aug 2023

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The global HER2 Targeted Therapy market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global HER2 Targeted Therapy demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for HER2 Targeted Therapy, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of HER2 Targeted Therapy that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global HER2 Targeted Therapy total market, 2018-2029, (USD Million)
Global HER2 Targeted Therapy total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: HER2 Targeted Therapy total market, key domestic companies and share, (USD Million)
Global HER2 Targeted Therapy revenue by player and market share 2018-2023, (USD Million)
Global HER2 Targeted Therapy total market by Type, CAGR, 2018-2029, (USD Million)
Global HER2 Targeted Therapy total market by Application, CAGR, 2018-2029, (USD Million).

This reports profiles major players in the global HER2 Targeted Therapy market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GlaxoSmithKline, Bayer, Abbott, AbbVie, Pfizer, Sanofi, Agilent, Glenmark Pharmaceuticals and Merck, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World HER2 Targeted Therapy market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global HER2 Targeted Therapy Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global HER2 Targeted Therapy Market, Segmentation by Type
Monotherapy
Combination Therapy
Others

Global HER2 Targeted Therapy Market, Segmentation by Application
Breast Cancer
Stomach Cancer
Head and Neck Cancer
Lung Cancer
Ovarian Cancer
Others

Companies Profiled:
GlaxoSmithKline
Bayer
Abbott
AbbVie
Pfizer
Sanofi
Agilent
Glenmark Pharmaceuticals
Merck
Roche
Novartis
Astra Zeneca
Daiichi Sankyo

Key Questions Answered
1. How big is the global HER2 Targeted Therapy market?
2. What is the demand of the global HER2 Targeted Therapy market?
3. What is the year over year growth of the global HER2 Targeted Therapy market?
4. What is the total value of the global HER2 Targeted Therapy market?
5. Who are the major players in the global HER2 Targeted Therapy market?

Table of Contents

1 Supply Summary
    1.1 HER2 Targeted Therapy Introduction
    1.2 World HER2 Targeted Therapy Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World HER2 Targeted Therapy Total Market by Region (by Headquarter Location)
        1.3.1 World HER2 Targeted Therapy Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States HER2 Targeted Therapy Market Size (2018-2029)
        1.3.3 China HER2 Targeted Therapy Market Size (2018-2029)
        1.3.4 Europe HER2 Targeted Therapy Market Size (2018-2029)
        1.3.5 Japan HER2 Targeted Therapy Market Size (2018-2029)
        1.3.6 South Korea HER2 Targeted Therapy Market Size (2018-2029)
        1.3.7 ASEAN HER2 Targeted Therapy Market Size (2018-2029)
        1.3.8 India HER2 Targeted Therapy Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 HER2 Targeted Therapy Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 HER2 Targeted Therapy Major Market Trends

2 Demand Summary
    2.1 World HER2 Targeted Therapy Consumption Value (2018-2029)
    2.2 World HER2 Targeted Therapy Consumption Value by Region
        2.2.1 World HER2 Targeted Therapy Consumption Value by Region (2018-2023)
        2.2.2 World HER2 Targeted Therapy Consumption Value Forecast by Region (2024-2029)
    2.3 United States HER2 Targeted Therapy Consumption Value (2018-2029)
    2.4 China HER2 Targeted Therapy Consumption Value (2018-2029)
    2.5 Europe HER2 Targeted Therapy Consumption Value (2018-2029)
    2.6 Japan HER2 Targeted Therapy Consumption Value (2018-2029)
    2.7 South Korea HER2 Targeted Therapy Consumption Value (2018-2029)
    2.8 ASEAN HER2 Targeted Therapy Consumption Value (2018-2029)
    2.9 India HER2 Targeted Therapy Consumption Value (2018-2029)

3 World HER2 Targeted Therapy Companies Competitive Analysis
    3.1 World HER2 Targeted Therapy Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global HER2 Targeted Therapy Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for HER2 Targeted Therapy in 2022
        3.2.3 Global Concentration Ratios (CR8) for HER2 Targeted Therapy in 2022
    3.3 HER2 Targeted Therapy Company Evaluation Quadrant
    3.4 HER2 Targeted Therapy Market: Overall Company Footprint Analysis
        3.4.1 HER2 Targeted Therapy Market: Region Footprint
        3.4.2 HER2 Targeted Therapy Market: Company Product Type Footprint
        3.4.3 HER2 Targeted Therapy Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: HER2 Targeted Therapy Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: HER2 Targeted Therapy Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: HER2 Targeted Therapy Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: HER2 Targeted Therapy Consumption Value Comparison
        4.2.1 United States VS China: HER2 Targeted Therapy Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: HER2 Targeted Therapy Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based HER2 Targeted Therapy Companies and Market Share, 2018-2023
        4.3.1 United States Based HER2 Targeted Therapy Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies HER2 Targeted Therapy Revenue, (2018-2023)
    4.4 China Based Companies HER2 Targeted Therapy Revenue and Market Share, 2018-2023
        4.4.1 China Based HER2 Targeted Therapy Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies HER2 Targeted Therapy Revenue, (2018-2023)
    4.5 Rest of World Based HER2 Targeted Therapy Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based HER2 Targeted Therapy Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies HER2 Targeted Therapy Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World HER2 Targeted Therapy Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Monotherapy
        5.2.2 Combination Therapy
        5.2.3 Others
    5.3 Market Segment by Type
        5.3.1 World HER2 Targeted Therapy Market Size by Type (2018-2023)
        5.3.2 World HER2 Targeted Therapy Market Size by Type (2024-2029)
        5.3.3 World HER2 Targeted Therapy Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World HER2 Targeted Therapy Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Breast Cancer
        6.2.2 Stomach Cancer
        6.2.3 Head and Neck Cancer
        6.2.4 Lung Cancer
        6.2.5 Lung Cancer
        6.2.6 Others
    6.3 Market Segment by Application
        6.3.1 World HER2 Targeted Therapy Market Size by Application (2018-2023)
        6.3.2 World HER2 Targeted Therapy Market Size by Application (2024-2029)
        6.3.3 World HER2 Targeted Therapy Market Size by Application (2018-2029)

7 Company Profiles
    7.1 GlaxoSmithKline
        7.1.1 GlaxoSmithKline Details
        7.1.2 GlaxoSmithKline Major Business
        7.1.3 GlaxoSmithKline HER2 Targeted Therapy Product and Services
        7.1.4 GlaxoSmithKline HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 GlaxoSmithKline Recent Developments/Updates
        7.1.6 GlaxoSmithKline Competitive Strengths & Weaknesses
    7.2 Bayer
        7.2.1 Bayer Details
        7.2.2 Bayer Major Business
        7.2.3 Bayer HER2 Targeted Therapy Product and Services
        7.2.4 Bayer HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 Bayer Recent Developments/Updates
        7.2.6 Bayer Competitive Strengths & Weaknesses
    7.3 Abbott
        7.3.1 Abbott Details
        7.3.2 Abbott Major Business
        7.3.3 Abbott HER2 Targeted Therapy Product and Services
        7.3.4 Abbott HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 Abbott Recent Developments/Updates
        7.3.6 Abbott Competitive Strengths & Weaknesses
    7.4 AbbVie
        7.4.1 AbbVie Details
        7.4.2 AbbVie Major Business
        7.4.3 AbbVie HER2 Targeted Therapy Product and Services
        7.4.4 AbbVie HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 AbbVie Recent Developments/Updates
        7.4.6 AbbVie Competitive Strengths & Weaknesses
    7.5 Pfizer
        7.5.1 Pfizer Details
        7.5.2 Pfizer Major Business
        7.5.3 Pfizer HER2 Targeted Therapy Product and Services
        7.5.4 Pfizer HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 Pfizer Recent Developments/Updates
        7.5.6 Pfizer Competitive Strengths & Weaknesses
    7.6 Sanofi
        7.6.1 Sanofi Details
        7.6.2 Sanofi Major Business
        7.6.3 Sanofi HER2 Targeted Therapy Product and Services
        7.6.4 Sanofi HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 Sanofi Recent Developments/Updates
        7.6.6 Sanofi Competitive Strengths & Weaknesses
    7.7 Agilent
        7.7.1 Agilent Details
        7.7.2 Agilent Major Business
        7.7.3 Agilent HER2 Targeted Therapy Product and Services
        7.7.4 Agilent HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.7.5 Agilent Recent Developments/Updates
        7.7.6 Agilent Competitive Strengths & Weaknesses
    7.8 Glenmark Pharmaceuticals
        7.8.1 Glenmark Pharmaceuticals Details
        7.8.2 Glenmark Pharmaceuticals Major Business
        7.8.3 Glenmark Pharmaceuticals HER2 Targeted Therapy Product and Services
        7.8.4 Glenmark Pharmaceuticals HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.8.5 Glenmark Pharmaceuticals Recent Developments/Updates
        7.8.6 Glenmark Pharmaceuticals Competitive Strengths & Weaknesses
    7.9 Merck
        7.9.1 Merck Details
        7.9.2 Merck Major Business
        7.9.3 Merck HER2 Targeted Therapy Product and Services
        7.9.4 Merck HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.9.5 Merck Recent Developments/Updates
        7.9.6 Merck Competitive Strengths & Weaknesses
    7.10 Roche
        7.10.1 Roche Details
        7.10.2 Roche Major Business
        7.10.3 Roche HER2 Targeted Therapy Product and Services
        7.10.4 Roche HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.10.5 Roche Recent Developments/Updates
        7.10.6 Roche Competitive Strengths & Weaknesses
    7.11 Novartis
        7.11.1 Novartis Details
        7.11.2 Novartis Major Business
        7.11.3 Novartis HER2 Targeted Therapy Product and Services
        7.11.4 Novartis HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.11.5 Novartis Recent Developments/Updates
        7.11.6 Novartis Competitive Strengths & Weaknesses
    7.12 Astra Zeneca
        7.12.1 Astra Zeneca Details
        7.12.2 Astra Zeneca Major Business
        7.12.3 Astra Zeneca HER2 Targeted Therapy Product and Services
        7.12.4 Astra Zeneca HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.12.5 Astra Zeneca Recent Developments/Updates
        7.12.6 Astra Zeneca Competitive Strengths & Weaknesses
    7.13 Daiichi Sankyo
        7.13.1 Daiichi Sankyo Details
        7.13.2 Daiichi Sankyo Major Business
        7.13.3 Daiichi Sankyo HER2 Targeted Therapy Product and Services
        7.13.4 Daiichi Sankyo HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.13.5 Daiichi Sankyo Recent Developments/Updates
        7.13.6 Daiichi Sankyo Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 HER2 Targeted Therapy Industry Chain
    8.2 HER2 Targeted Therapy Upstream Analysis
    8.3 HER2 Targeted Therapy Midstream Analysis
    8.4 HER2 Targeted Therapy Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World HER2 Targeted Therapy Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World HER2 Targeted Therapy Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World HER2 Targeted Therapy Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World HER2 Targeted Therapy Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World HER2 Targeted Therapy Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World HER2 Targeted Therapy Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World HER2 Targeted Therapy Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World HER2 Targeted Therapy Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World HER2 Targeted Therapy Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key HER2 Targeted Therapy Players in 2022
    Table 12. World HER2 Targeted Therapy Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global HER2 Targeted Therapy Company Evaluation Quadrant
    Table 14. Head Office of Key HER2 Targeted Therapy Player
    Table 15. HER2 Targeted Therapy Market: Company Product Type Footprint
    Table 16. HER2 Targeted Therapy Market: Company Product Application Footprint
    Table 17. HER2 Targeted Therapy Mergers & Acquisitions Activity
    Table 18. United States VS China HER2 Targeted Therapy Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China HER2 Targeted Therapy Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based HER2 Targeted Therapy Companies, Headquarters (States, Country)
    Table 21. United States Based Companies HER2 Targeted Therapy Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies HER2 Targeted Therapy Revenue Market Share (2018-2023)
    Table 23. China Based HER2 Targeted Therapy Companies, Headquarters (Province, Country)
    Table 24. China Based Companies HER2 Targeted Therapy Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies HER2 Targeted Therapy Revenue Market Share (2018-2023)
    Table 26. Rest of World Based HER2 Targeted Therapy Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies HER2 Targeted Therapy Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies HER2 Targeted Therapy Revenue Market Share (2018-2023)
    Table 29. World HER2 Targeted Therapy Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World HER2 Targeted Therapy Market Size by Type (2018-2023) & (USD Million)
    Table 31. World HER2 Targeted Therapy Market Size by Type (2024-2029) & (USD Million)
    Table 32. World HER2 Targeted Therapy Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World HER2 Targeted Therapy Market Size by Application (2018-2023) & (USD Million)
    Table 34. World HER2 Targeted Therapy Market Size by Application (2024-2029) & (USD Million)
    Table 35. GlaxoSmithKline Basic Information, Area Served and Competitors
    Table 36. GlaxoSmithKline Major Business
    Table 37. GlaxoSmithKline HER2 Targeted Therapy Product and Services
    Table 38. GlaxoSmithKline HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. GlaxoSmithKline Recent Developments/Updates
    Table 40. GlaxoSmithKline Competitive Strengths & Weaknesses
    Table 41. Bayer Basic Information, Area Served and Competitors
    Table 42. Bayer Major Business
    Table 43. Bayer HER2 Targeted Therapy Product and Services
    Table 44. Bayer HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. Bayer Recent Developments/Updates
    Table 46. Bayer Competitive Strengths & Weaknesses
    Table 47. Abbott Basic Information, Area Served and Competitors
    Table 48. Abbott Major Business
    Table 49. Abbott HER2 Targeted Therapy Product and Services
    Table 50. Abbott HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. Abbott Recent Developments/Updates
    Table 52. Abbott Competitive Strengths & Weaknesses
    Table 53. AbbVie Basic Information, Area Served and Competitors
    Table 54. AbbVie Major Business
    Table 55. AbbVie HER2 Targeted Therapy Product and Services
    Table 56. AbbVie HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. AbbVie Recent Developments/Updates
    Table 58. AbbVie Competitive Strengths & Weaknesses
    Table 59. Pfizer Basic Information, Area Served and Competitors
    Table 60. Pfizer Major Business
    Table 61. Pfizer HER2 Targeted Therapy Product and Services
    Table 62. Pfizer HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. Pfizer Recent Developments/Updates
    Table 64. Pfizer Competitive Strengths & Weaknesses
    Table 65. Sanofi Basic Information, Area Served and Competitors
    Table 66. Sanofi Major Business
    Table 67. Sanofi HER2 Targeted Therapy Product and Services
    Table 68. Sanofi HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 69. Sanofi Recent Developments/Updates
    Table 70. Sanofi Competitive Strengths & Weaknesses
    Table 71. Agilent Basic Information, Area Served and Competitors
    Table 72. Agilent Major Business
    Table 73. Agilent HER2 Targeted Therapy Product and Services
    Table 74. Agilent HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 75. Agilent Recent Developments/Updates
    Table 76. Agilent Competitive Strengths & Weaknesses
    Table 77. Glenmark Pharmaceuticals Basic Information, Area Served and Competitors
    Table 78. Glenmark Pharmaceuticals Major Business
    Table 79. Glenmark Pharmaceuticals HER2 Targeted Therapy Product and Services
    Table 80. Glenmark Pharmaceuticals HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 81. Glenmark Pharmaceuticals Recent Developments/Updates
    Table 82. Glenmark Pharmaceuticals Competitive Strengths & Weaknesses
    Table 83. Merck Basic Information, Area Served and Competitors
    Table 84. Merck Major Business
    Table 85. Merck HER2 Targeted Therapy Product and Services
    Table 86. Merck HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 87. Merck Recent Developments/Updates
    Table 88. Merck Competitive Strengths & Weaknesses
    Table 89. Roche Basic Information, Area Served and Competitors
    Table 90. Roche Major Business
    Table 91. Roche HER2 Targeted Therapy Product and Services
    Table 92. Roche HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 93. Roche Recent Developments/Updates
    Table 94. Roche Competitive Strengths & Weaknesses
    Table 95. Novartis Basic Information, Area Served and Competitors
    Table 96. Novartis Major Business
    Table 97. Novartis HER2 Targeted Therapy Product and Services
    Table 98. Novartis HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 99. Novartis Recent Developments/Updates
    Table 100. Novartis Competitive Strengths & Weaknesses
    Table 101. Astra Zeneca Basic Information, Area Served and Competitors
    Table 102. Astra Zeneca Major Business
    Table 103. Astra Zeneca HER2 Targeted Therapy Product and Services
    Table 104. Astra Zeneca HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 105. Astra Zeneca Recent Developments/Updates
    Table 106. Daiichi Sankyo Basic Information, Area Served and Competitors
    Table 107. Daiichi Sankyo Major Business
    Table 108. Daiichi Sankyo HER2 Targeted Therapy Product and Services
    Table 109. Daiichi Sankyo HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 110. Global Key Players of HER2 Targeted Therapy Upstream (Raw Materials)
    Table 111. HER2 Targeted Therapy Typical Customers
List of Figure
    Figure 1. HER2 Targeted Therapy Picture
    Figure 2. World HER2 Targeted Therapy Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World HER2 Targeted Therapy Total Market Size (2018-2029) & (USD Million)
    Figure 4. World HER2 Targeted Therapy Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World HER2 Targeted Therapy Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company HER2 Targeted Therapy Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company HER2 Targeted Therapy Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company HER2 Targeted Therapy Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company HER2 Targeted Therapy Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company HER2 Targeted Therapy Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company HER2 Targeted Therapy Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company HER2 Targeted Therapy Revenue (2018-2029) & (USD Million)
    Figure 13. HER2 Targeted Therapy Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World HER2 Targeted Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 16. World HER2 Targeted Therapy Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States HER2 Targeted Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 18. China HER2 Targeted Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe HER2 Targeted Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan HER2 Targeted Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea HER2 Targeted Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN HER2 Targeted Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 23. India HER2 Targeted Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of HER2 Targeted Therapy by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for HER2 Targeted Therapy Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for HER2 Targeted Therapy Markets in 2022
    Figure 27. United States VS China: HER2 Targeted Therapy Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: HER2 Targeted Therapy Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World HER2 Targeted Therapy Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World HER2 Targeted Therapy Market Size Market Share by Type in 2022
    Figure 31. Monotherapy
    Figure 32. Combination Therapy
    Figure 33. Others
    Figure 34. World HER2 Targeted Therapy Market Size Market Share by Type (2018-2029)
    Figure 35. World HER2 Targeted Therapy Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 36. World HER2 Targeted Therapy Market Size Market Share by Application in 2022
    Figure 37. Breast Cancer
    Figure 38. Stomach Cancer
    Figure 39. Head and Neck Cancer
    Figure 40. Lung Cancer
    Figure 41. Ovarian Cancer
    Figure 42. Others
    Figure 43. HER2 Targeted Therapy Industrial Chain
    Figure 44. Methodology
    Figure 45. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

GlaxoSmithKline
Bayer
Abbott
AbbVie
Pfizer
Sanofi
Agilent
Glenmark Pharmaceuticals
Merck
Roche
Novartis
Astra Zeneca
Daiichi Sankyo

Related Reports

Global HER2 Targeted Therapy Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global HER2 Targeted Therapy Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 30 Aug 2023

date Medical Care

According to our (Global Info Research) latest study, the global HER2 Targeted Therapy market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.

Global HER2 Targeted Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global HER2 Targeted Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 10 Jan 2024

date Medical Care

According to our (Global Info Research) latest study, the global HER2 Targeted Therapy market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Global HER2 Targeted Therapy Supply, Demand and Key Producers, 2024-2030

Global HER2 Targeted Therapy Supply, Demand and Key Producers, 2024-2030

date 19 Feb 2024

date Medical Care

The global HER2 Targeted Therapy market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

Product Tags

HER2 Targeted Therapy

Organ Rejection Prophylaxis Treatment

Biologics Analytical Services

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>